Join expert faculty for an interactive discussion focused on real‑world decision making for antiretroviral therapy (ART). Through case examples, we will explore common scenarios: factoring resistance into initial ART choice for treatment‑naïve patients, pre‑switch assessment for virally suppressed patients considering a regimen change, and how prior PrEP use affects subsequent ART selection. This webinar will equip clinicians with practical knowledge and tools to assess and manage ART resistance in today’s evolving clinical landscape.
As HIV prevention evolves, long-acting injectable options like lenacapavir are emerging as promising tools to expand access and adherence. Effective implementation of new interventions calls for thoughtful planning across key areas, including operations, staffing, finance, and patient access.
This webinar covers patient navigation touchpoints along the PrEP continuum for injectable lenacapavir, patient education strategies, expanding the capacity of PrEP navigation staff to implement injectable PrEP, and future opportunities for expanded implementation in mobile health settings.
In the first webinar of the series, faculty – including principal investigators from the PURPOSE trials – review clinical data and delve into opportunities and challenges for the real-world implementation of lenacapavir as PrEP.
This webinar covers medication administration, managing side effects, potential drug interactions, and transitioning patients on or off lenacapavir as PrEP.